Nippon Shinyaku Co.,Ltd. Logo

Nippon Shinyaku Co.,Ltd.

Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.

4516 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
京都市南区吉祥院西ノ庄門口町14番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nippon Shinyaku Co., Ltd. is a research and development-oriented company engaged in the manufacturing and commercialization of pharmaceuticals and functional foods. The company's core business is its Pharmaceuticals division, which develops and sells a range of prescribed drugs, including specialty and generic medications, with a focus on therapeutic areas such as urinary, neurological, respiratory, and circulatory disorders. The Functional Foods division leverages the company's pharmaceutical expertise to produce and market high-quality health food products. Nippon Shinyaku is committed to supplying original, high-quality products to contribute to the healthcare sector and improve wellbeing.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Nippon Shinyaku Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-04 06:16
Regulatory News Service
臨時報告書
Japanese 27.7 KB
2025-06-24 06:23
Regulatory News Service
確認書
Japanese 8.6 KB
2025-06-24 06:22
Regulatory News Service
内部統制報告書-第162期(2024/04/01-2025/03/31)
Japanese 26.1 KB
2025-06-24 06:18
Annual Report
有価証券報告書-第162期(2024/04/01-2025/03/31)
Japanese 1.6 MB
2024-11-14 02:12
Regulatory News Service
確認書
Japanese 8.6 KB
2024-11-14 02:11
Interim Report
半期報告書-第162期(2024/04/01-2025/03/31)
Japanese 233.5 KB
2024-07-01 04:04
Regulatory News Service
臨時報告書
Japanese 29.3 KB
2024-06-28 04:07
Regulatory News Service
内部統制報告書-第161期(2023/04/01-2024/03/31)
Japanese 23.3 KB
2024-06-28 04:01
Regulatory News Service
確認書
Japanese 8.6 KB
2024-06-28 03:58
Annual Report
有価証券報告書-第161期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-02-14 02:06
Regulatory News Service
確認書
Japanese 8.6 KB
2024-02-14 02:05
Quarterly Report
四半期報告書-第161期第3四半期(2023/10/01-2023/12/31)
Japanese 244.8 KB
2023-11-14 01:59
Regulatory News Service
確認書
Japanese 8.6 KB
2023-11-14 01:59
Quarterly Report
四半期報告書-第161期第2四半期(2023/07/01-2023/09/30)
Japanese 262.0 KB
2023-08-14 03:04
Regulatory News Service
確認書
Japanese 8.6 KB

Automate Your Workflow. Get a real-time feed of all Nippon Shinyaku Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Nippon Shinyaku Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France GNFT
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark GMAB
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK

Talk to a Data Expert

Have a question? We'll get back to you promptly.